Introduction: body mass index (BMI) is used worldwide to track excess weight; however, it has limitations in predicting body fat percentage (BF%). Triponderal mass index (TMI) has been studied as an alternative indicator to predict BF%.
Objective: to compare BMI and TMI as predictors of BF% and develop TMI cutoff points for screening high adiposity in Brazilian children and adolescentes.
Background: Biological therapies, such as mepolizumab, have transformed the treatment of severe eosinophilic asthma. Although mepolizumab's short-term effectiveness is established, there is limited evidence on its ability to achieve long-term clinical remission.
Objective: To evaluate the long-term effectiveness and safety of mepolizumab, explore its potential to induce clinical and sustained remission, and identify baseline factors associated with the likelihood of achieving remission over 24 months.
Objective: To present the different aspects that may be involved in the genesis and maintenance of obesity in children and adolescents.
Data Source: Narrative review of articles published in the PubMed, Scielo, Lilacs, Scopus and Google Scholar databases, using the search terms: overweight, obesity, pre-conception, prenatal, infants, schoolchildren, children, and adolescents. The search was conducted in studies written in Portuguese, English and Spanish, including narrative, integrative or systematic reviews, meta-analyses, cross-sectional, case-control and cohort studies, published between 2003 and 2023.
Children (Basel)
March 2023
Objective: To determine if oral nutritional supplementation of picky eater children has a beneficial effect in addition to nutritional guidance on anthropometric parameters, nutrient intake, appetite, physical activity, and health complications.
Methods: This is a randomized, single-blind, controlled clinical trial that included Brazilian picky eater children aged 24 to 60 months. The individuals were randomized into a control group (CG) ( = 17) and an intervention group (IG) ( = 18), and were followed up in seven meetings for 180 days (baseline plus one meeting every 30 days).